Cargando…
Efficiency of CAR-T Therapy for Treatment of Solid Tumor in Clinical Trials: A Meta-Analysis
BACKGROUND: Chimeric antigen receptor T (CAR-T) cell therapy has achieved unprecedented success among hematologic tumors, but its role in treating solid tumors is still unclear. METHODS: A comprehensive search of electronic databases up to June 1, 2018, was carried out by two independent reviewers....
Autores principales: | Hou, Bin, Tang, Yao, Li, Wenhan, Zeng, Qingnuo, Chang, Dongmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388318/ https://www.ncbi.nlm.nih.gov/pubmed/30886654 http://dx.doi.org/10.1155/2019/3425291 |
Ejemplares similares
-
Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway
por: Hou, Bin, et al.
Publicado: (2020) -
LHPP suppresses colorectal cancer cell migration and invasion in vitro and in vivo by inhibiting Smad3 phosphorylation in the TGF-β pathway
por: Hou, Bin, et al.
Publicado: (2021) -
Clinical Investigations of CAR-T Cell Therapy for Solid Tumors
por: Chen, Kun, et al.
Publicado: (2022) -
CAR T cell therapy in solid tumors: A review of current clinical trials
por: Patel, Urvi, et al.
Publicado: (2021) -
CAR-T Therapies in Solid Tumors: Opportunities and Challenges
por: Guzman, Grace, et al.
Publicado: (2023)